Pre-treatment neutrophil to lymphocyte ratio as an independent prognostic factor in patients with treated with everolimus for metastatic renal cell carcinoma
2013-01-01 Santoni, M; De Giorgi, U; Iacovelli, R; Conti, A; Burattini, L; Rossi, L; Luca Burgio, S; Berardi, R; Muzzonigro, G; Cortesi, E; Amadori, D; Cascinu, Stefano
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients
2013-01-01 Scartozzi, M; Giampieri, R; Loretelli, C; Bittoni, A; Mandolesi, A; Faloppi, L; Bianconi, M; Del Prete, M; Andrikou, K; Bearzi, I; Cascinu, Stefano
Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma
2013-01-01 Santoni, M; Scoccianti, S; Lolli, I; Fabrini, Mg; Silvano, G; Detti, B; Perrone, F; Savio, G; Iacovelli, R; Burattini, L; Berardi, R; Cascinu, Stefano
Progress of molecular targeted therapies for advanced renal cell carcinoma
2013-01-01 Conti, A; Santoni, M; Amantini, C; Burattini, L; Berardi, R; Santoni, G; Cascinu, Stefano; Muzzonigro, G.
Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer
2013-01-01 Berardi, R; Santoni, M; Morgese, F; Ballatore, Z; Savini, A; Onofri, A; Mazzanti, P; Pistelli, M; Pierantoni, C; De Lisa, M; Caramanti, M; Pagliaretta, S; Pellei, C; Cascinu, Stefano
Long-term results of preoperative 5-fluorouracil-oxaliplatin chemoradiation therapy in locally advanced rectal cancer
2013-01-01 E., Fontana; F., Pucci; R., Camisa; S., Bui; S., Galdy; F., Leonardi; F. V., Negri; E., Anselmi; P. L., Losardo; L., Roncoroni; P., Dell'Abate; P., Crafa; Cascinu, Stefano; A., Ardizzoni
Prognostic factors in early-stage triple-negative breast cancer: lessons and limits from clinical practice
2013-01-01 Pistelli, M.; Pagliacci, A.; Battelli, N.; Santinelli, A.; Biscotti, T.; Ballatore, Z.; Berardi, R.; Cascinu, Stefano
Compliance with breast and cervical cancer screening programs in women: results from a population-based study
2013-01-01 Berardi, R; Nacciarriti, D; Tamburrano, T; Carbonari, G; Romagnoli, E; Duca, M; Burattini, M; Silva, Rr; Cellerino, R; Cascinu, Stefano
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib
2013-01-01 Scartozzi, M.; Bianconi, M.; Faloppi, L.; Loretelli, C.; Bittoni, A.; Del Prete, M.; Giampieri, R.; Maccaroni, E.; Nicoletti, S.; Burattini, L.; Minardi, D.; Muzzonigro, G.; Montironi, R.; Cascinu, Stefano
Twice-daily dosing of temozolomide in combination with fotemustine for the treatment of patients with refractory glioblastoma
2012-01-01 M., Santoni; A., Paccapelo; L., Burattini; A., Onofri; Cascinu, Stefano
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients
2012-01-01 M., Scartozzi; R., Giampieri; E., Maccaroni; M. D., Prete; L., Faloppi; M., Bianconi; E., Galizia; C., Loretelli; L., Belvederesi; A., Bittoni; Cascinu, Stefano
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab
2012-01-01 M., Scartozzi; R., Giampieri; E., Maccaroni; A., Mandolesi; S., Biagetti; S., Alfonsi; L., Giustini; C., Loretelli; L., Faloppi; A., Bittoni; M., Bianconi; M. D., Prete; I., Bearzi; Cascinu, Stefano
Nuclear factor-κB predicts outcome in locally advanced rectal cancer patients receiving neoadjuvant radio-chemotherapy
2012-01-01 R., Berardi; E., Maccaroni; A., Mandolesi; G., Mantello; A., Onofri; T., Biscotti; C., Pierantoni; W., Siquini; C., Marmorale; M., Guerrieri; I., Bearzi; Cascinu, Stefano
Cetuximab: still an option in the treatment of pancreatic cancer?
2013-01-01 Faloppi, L; Andrikou, K; Cascinu, Stefano
VEGF expression and response to sunitinib in patients with metastatic clear cell renal cell carcinoma
2013-01-01 Minardi, D.; Lucarini, G.; Santoni, M.; Mazzucchelli, R.; Burattini, L.; Pistelli, M.; Bianconi, M.; DI Primio, R.; Scartozzi, M.; Montironi, R.; Cascinu, Stefano; Muzzonigro, G.
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab
2013-01-01 Scartozzi, M; Giampieri, R; Loretelli, C; Mandolesi, A; del Prete, M; Biagetti, S; Alfonsi, S; Faloppi, L; Bianconi, M; Bittoni, A; Bearzi, I; Cascinu, Stefano
Are post-docetaxel treatments effective in patients with castration-resistant prostate cancer and performance of 2? A meta-analysis of published trials
2013-01-01 Iacovelli, R; Altavilla, A; Procopio, G; Bracarda, S; Santoni, M; Cascinu, Stefano; Cortesi, E.
Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma
2013-01-01 Santoni, M.; Massari, F.; Amantini, C.; Nabissi, M.; Maines, F.; Burattini, L.; Berardi, R.; Santoni, G.; Montironi, R.; Tortora, G.; Cascinu, Stefano
Adjuvant chemotherapy in colon cancer: can we improve quality of care?
2013-01-01 Cascinu, Stefano
Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovation
2013-01-01 Giampieri, R; Scartozzi, M; Del Prete, M; Maccaroni, E; Bittoni, A; Faloppi, L; Bianconi, M; Cecchini, L; Cascinu, Stefano
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Pre-treatment neutrophil to lymphocyte ratio as an independent prognostic factor in patients with treated with everolimus for metastatic renal cell carcinoma | 1-gen-2013 | Santoni, M; De Giorgi, U; Iacovelli, R; Conti, A; Burattini, L; Rossi, L; Luca Burgio, S; Berardi, R; Muzzonigro, G; Cortesi, E; Amadori, D; Cascinu, Stefano | |
| Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients | 1-gen-2013 | Scartozzi, M; Giampieri, R; Loretelli, C; Bittoni, A; Mandolesi, A; Faloppi, L; Bianconi, M; Del Prete, M; Andrikou, K; Bearzi, I; Cascinu, Stefano | |
| Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma | 1-gen-2013 | Santoni, M; Scoccianti, S; Lolli, I; Fabrini, Mg; Silvano, G; Detti, B; Perrone, F; Savio, G; Iacovelli, R; Burattini, L; Berardi, R; Cascinu, Stefano | |
| Progress of molecular targeted therapies for advanced renal cell carcinoma | 1-gen-2013 | Conti, A; Santoni, M; Amantini, C; Burattini, L; Berardi, R; Santoni, G; Cascinu, Stefano; Muzzonigro, G. | |
| Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer | 1-gen-2013 | Berardi, R; Santoni, M; Morgese, F; Ballatore, Z; Savini, A; Onofri, A; Mazzanti, P; Pistelli, M; Pierantoni, C; De Lisa, M; Caramanti, M; Pagliaretta, S; Pellei, C; Cascinu, Stefano | |
| Long-term results of preoperative 5-fluorouracil-oxaliplatin chemoradiation therapy in locally advanced rectal cancer | 1-gen-2013 | E., Fontana; F., Pucci; R., Camisa; S., Bui; S., Galdy; F., Leonardi; F. V., Negri; E., Anselmi; P. L., Losardo; L., Roncoroni; P., Dell'Abate; P., Crafa; Cascinu, Stefano; A., Ardizzoni | |
| Prognostic factors in early-stage triple-negative breast cancer: lessons and limits from clinical practice | 1-gen-2013 | Pistelli, M.; Pagliacci, A.; Battelli, N.; Santinelli, A.; Biscotti, T.; Ballatore, Z.; Berardi, R.; Cascinu, Stefano | |
| Compliance with breast and cervical cancer screening programs in women: results from a population-based study | 1-gen-2013 | Berardi, R; Nacciarriti, D; Tamburrano, T; Carbonari, G; Romagnoli, E; Duca, M; Burattini, M; Silva, Rr; Cellerino, R; Cascinu, Stefano | |
| VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib | 1-gen-2013 | Scartozzi, M.; Bianconi, M.; Faloppi, L.; Loretelli, C.; Bittoni, A.; Del Prete, M.; Giampieri, R.; Maccaroni, E.; Nicoletti, S.; Burattini, L.; Minardi, D.; Muzzonigro, G.; Montironi, R.; Cascinu, Stefano | |
| Twice-daily dosing of temozolomide in combination with fotemustine for the treatment of patients with refractory glioblastoma | 1-gen-2012 | M., Santoni; A., Paccapelo; L., Burattini; A., Onofri; Cascinu, Stefano | |
| Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients | 1-gen-2012 | M., Scartozzi; R., Giampieri; E., Maccaroni; M. D., Prete; L., Faloppi; M., Bianconi; E., Galizia; C., Loretelli; L., Belvederesi; A., Bittoni; Cascinu, Stefano | |
| Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab | 1-gen-2012 | M., Scartozzi; R., Giampieri; E., Maccaroni; A., Mandolesi; S., Biagetti; S., Alfonsi; L., Giustini; C., Loretelli; L., Faloppi; A., Bittoni; M., Bianconi; M. D., Prete; I., Bearzi; Cascinu, Stefano | |
| Nuclear factor-κB predicts outcome in locally advanced rectal cancer patients receiving neoadjuvant radio-chemotherapy | 1-gen-2012 | R., Berardi; E., Maccaroni; A., Mandolesi; G., Mantello; A., Onofri; T., Biscotti; C., Pierantoni; W., Siquini; C., Marmorale; M., Guerrieri; I., Bearzi; Cascinu, Stefano | |
| Cetuximab: still an option in the treatment of pancreatic cancer? | 1-gen-2013 | Faloppi, L; Andrikou, K; Cascinu, Stefano | |
| VEGF expression and response to sunitinib in patients with metastatic clear cell renal cell carcinoma | 1-gen-2013 | Minardi, D.; Lucarini, G.; Santoni, M.; Mazzucchelli, R.; Burattini, L.; Pistelli, M.; Bianconi, M.; DI Primio, R.; Scartozzi, M.; Montironi, R.; Cascinu, Stefano; Muzzonigro, G. | |
| Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab | 1-gen-2013 | Scartozzi, M; Giampieri, R; Loretelli, C; Mandolesi, A; del Prete, M; Biagetti, S; Alfonsi, S; Faloppi, L; Bianconi, M; Bittoni, A; Bearzi, I; Cascinu, Stefano | |
| Are post-docetaxel treatments effective in patients with castration-resistant prostate cancer and performance of 2? A meta-analysis of published trials | 1-gen-2013 | Iacovelli, R; Altavilla, A; Procopio, G; Bracarda, S; Santoni, M; Cascinu, Stefano; Cortesi, E. | |
| Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma | 1-gen-2013 | Santoni, M.; Massari, F.; Amantini, C.; Nabissi, M.; Maines, F.; Burattini, L.; Berardi, R.; Santoni, G.; Montironi, R.; Tortora, G.; Cascinu, Stefano | |
| Adjuvant chemotherapy in colon cancer: can we improve quality of care? | 1-gen-2013 | Cascinu, Stefano | |
| Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovation | 1-gen-2013 | Giampieri, R; Scartozzi, M; Del Prete, M; Maccaroni, E; Bittoni, A; Faloppi, L; Bianconi, M; Cecchini, L; Cascinu, Stefano |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista39392
Data di pubblicazione
- In corso di stampa9
- 2020 - 202711479
- 2010 - 201915948
- 2000 - 20097460
- 1990 - 19993485
- 1980 - 1989933
- 1970 - 197977
- 1959 - 19591
Editore
- Elsevier Inc.802
- Elsevier B.V.767
- John Wiley and Sons Inc524
- Springer Science and Business Med...517
- Oxford University Press483
- Lippincott Williams and Wilkins420
- Springer361
- MDPI347
- Elsevier Ltd330
- Springer Nature282
Rivista
- EUROPEAN UROLOGY529
- BLOOD372
- PLOS ONE312
- JOURNAL OF NEUROLOGY283
- EUROPEAN JOURNAL OF HEART FAILURE280
- NEUROLOGY268
- DIGESTIVE AND LIVER DISEASE245
- EUROPEAN HEART JOURNAL224
- MULTIPLE SCLEROSIS216
- SCIENTIFIC REPORTS212
Keyword
- Humans3553
- Male2080
- Female1864
- Middle Aged1472
- Aged1290
- Adult1100
- COVID-19629
- Retrospective Studies628
- Treatment Outcome603
- Prognosis481
Lingua
- eng28799
- ita1958
- fre64
- und55
- spa34
- ger25
- por12
- enm6
- rus6
- grc3
Accesso al fulltext
- no fulltext33612
- open3381
- reserved2292
- partially open99
- embargoed7
- mixed1